Obesity affects millions of older Americans and significantly increases the risk of serious medical conditions, including: Heart disease Stroke High blood pressure Type 2 diabetes Obstructive sleep apnea Osteoarthritis Metabolic dysfunction-associated steatotic liver disease (MASLD) For many years, Medicare generally did not cover medications prescribed solely for obesity treatment
This is a common concern for patients considering or taking this weight management medication
A comprehensive approach to treating both conditions typically involves removing trigger foods, addressing bacterial overgrowth with antimicrobials (herbal or conventional), and restoring gut health with probiotics
Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis
Our medical team performs the necessary evaluation, takes a medical history, and makes recommendations before starting any weight loss treatment
There are no published studies specifically examining fatigue outcomes in MS patients treated with semaglutide, and clinical experience suggests variable individual responses